Downsizing chronic disease management programs for type 2 diabetes patients during the COVID-19 pandemic: changes in healthcare utilization patterns
Downscaling CDMP care for type 2 diabetes patients during the COVID-19 pandemic was associated with temporary increases in hospital care for diabetes and regular GP care at various times during the pandemic. These findings may contribute to making informed decisions regarding measures during future pandemics, and, therefore, the pandemic provided a unique learning opportunity for the healthcare system in delivering appropriate care through CDMP. In future pandemics, it will be essential to implement adaptations such as telemedicine to mitigate health deterioration and alleviate pressure on other healthcare services.
Authors
- Lotte Ramerman (ORCID: https://orcid.org/0000-0001-8436-0924)
- Jean Muris (ORCID: https://orcid.org/0000-0002-8780-476X)
- Lilian L. Peters (ORCID: https://orcid.org/0000-0003-2342-0799)
- Robert Verheij (ORCID: https://orcid.org/0000-0003-2234-4819)
- Maarten Homburg
- Isabelle Bos (ORCID: https://orcid.org/0000-0001-9933-2758)
- Tim olde Hartman (ORCID: https://orcid.org/0000-0003-2078-1206)
- Corinne Rijpkema (ORCID: https://orcid.org/0000-0003-3319-5142)
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- Tilburg University (NL)
- Radboud University Medical Center (NL)
- Maastricht University (NL)
- Netherlands Institute for Health Services Research (NL)
- Zorginstituut Nederland (NL)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fmed.2025.1490175
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- ZonMw